Eurofins Healthcare targeted in alleged data breach by Nova ransomware group

• Ransomware group: Nova
• Country: France
• Sector: Healthcare
• Announcement date: July 18, 2025

Nova group claims data breach at Eurofins Healthcare

The threat actor known as Nova has claimed that data belonging to Eurofins Healthcare has been leaked. In an announcement made on July 18, 2025, the group asserted that they have successfully targeted the organization and gained unauthorized access to its internal systems. According to the claims made by the group, they have obtained sensitive data during this intrusion. Since the initial announcement on their leak site, the group has continued to maintain and reiterate their claims regarding the alleged data breach.

Ransomware groups often utilize leak sites to pressure victims into paying ransoms, a tactic frequently associated with double extortion. In such scenarios, attackers not only encrypt an organization's data to disrupt operations but also steal sensitive information to threaten its public release. This method increases the leverage the threat actor holds over the victim, as the exposure of confidential information can cause significant reputational and legal damage.

Details of the alleged leak

Despite the claims made by the Nova group regarding the successful acquisition of sensitive information, the group has not provided any specific details regarding the content of the allegedly leaked data. No screenshots or detailed information regarding the nature of the files have been provided to the public. Furthermore, the announcement did not include information regarding the total size of the data stolen or the specific number of files involved in the incident.

• No specific data types were named in the listing.

About Eurofins Healthcare

Eurofins Healthcare is part of Eurofins Scientific, a global life sciences company. The organization provides a comprehensive range of analytical testing and laboratory services across various sectors, including food, environment, pharmaceuticals, and cosmetics. With an extensive network of laboratories worldwide, the organization is a leader in the field of scientific analysis and testing.

Potential risks and industry implications

This incident may pose significant risks to data privacy within the healthcare sector where the organization operates. Depending on the nature of the data involved, legal sanctions and administrative fines under the General Data Protection Regulation (GDPR) could potentially arise. Such regulatory frameworks are designed to protect individual privacy, and breaches involving sensitive information often trigger rigorous investigations by governing bodies.

Beyond legal and regulatory concerns, secondary risks may emerge for the organization's employees and customers. These risks include the potential for identity theft or the deployment of targeted phishing attacks, where attackers use stolen information to deceive individuals. When sensitive personal or corporate data is compromised, the ripple effects can extend far beyond the immediate technical breach, impacting the trust and security of all stakeholders involved.

Information regarding the Nova group remains limited; therefore, the group's specific methods and motivations remain uncertain. For organizations operating in high-stakes sectors like healthcare, it is advisable to review data security processes and take necessary precautions against potential data breaches. Common defensive steps for organizations facing such threats include implementing robust multi-factor authentication, maintaining offline backups, and conducting regular security audits to identify vulnerabilities before they can be exploited by malicious actors.